Literature DB >> 20712533

NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss.

Debashree Mukherjea1, Sarvesh Jajoo, Kelly Sheehan, Tejbeer Kaur, Sandeep Sheth, Jennifer Bunch, Christopher Perro, Leonard P Rybak, Vickram Ramkumar.   

Abstract

Transient receptor potential vanilloid 1 (TRPV1) is implicated in cisplatin ototoxicity. Activation of this channel by cisplatin increases reactive oxygen species generation, which contribute to loss of outer hair cells in the cochlea. Knockdown of TRPV1 by short interfering RNA protected against cisplatin ototoxicity. In this study, we examined the mechanism underlying TRPV1-mediated ototoxicity using cultured organ of Corti transformed cells (UB/OC-1) and rats. Trans-tympanic injections of capsaicin produced transient hearing loss within 24 h, which recovered by 72 h. In UB/OC-1 cells, capsaicin increased NOX3 NADPH oxidase activity and activation of signal transducer and activator of transcription 1 (STAT1). Intratympanic administration of capsaicin transiently increased STAT1 activity and expression of downstream proinflammatory molecules. Capsaicin produced a transient increase in CD14-positive inflammatory cells into the cochlea, which mimicked the temporal course of STAT1 activation but did not alter the expression of apoptotic genes or damage to outer hair cells. In addition, trans-tympanic administration of STAT1 short interfering RNA protected against capsaicin-induced hearing loss. These data suggest that activation of TRPV1 mediates temporary hearing loss by initiating an inflammatory process in the cochlea via activation of NOX3 and STAT1. Thus, these proteins represent reasonable targets for ameliorating hearing loss.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20712533      PMCID: PMC3043978          DOI: 10.1089/ars.2010.3497

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  48 in total

1.  Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression.

Authors:  H Nguyen; C V Ramana; J Bayes; G R Stark
Journal:  J Biol Chem       Date:  2001-07-03       Impact factor: 5.157

2.  Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia.

Authors:  J B Davis; J Gray; M J Gunthorpe; J P Hatcher; P T Davey; P Overend; M H Harries; J Latcham; C Clapham; K Atkinson; S A Hughes; K Rance; E Grau; A J Harper; P L Pugh; D C Rogers; S Bingham; A Randall; S A Sheardown
Journal:  Nature       Date:  2000-05-11       Impact factor: 49.962

3.  Intense noise induces formation of vasoactive lipid peroxidation products in the cochlea.

Authors:  Y Ohinata; J M Miller; R A Altschuler; J Schacht
Journal:  Brain Res       Date:  2000-09-29       Impact factor: 3.252

4.  Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.

Authors:  Sarvesh Jajoo; Debashree Mukherjea; Kounosuke Watabe; Vickram Ramkumar
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

5.  Effect of proinflammatory cytokines on cultured spiral ligament fibrocytes.

Authors:  K Yoshida; I Ichimiya; M Suzuki; G Mogi
Journal:  Hear Res       Date:  1999-11       Impact factor: 3.208

6.  Requirement for STAT1 in LPS-induced gene expression in macrophages.

Authors:  Y Ohmori; T A Hamilton
Journal:  J Leukoc Biol       Date:  2001-04       Impact factor: 4.962

7.  Nitric oxide synthase inhibitor suppresses the ototoxic side effect of cisplatin in guinea pigs.

Authors:  K I Watanabe; A Hess; W Bloch; O Michel
Journal:  Anticancer Drugs       Date:  2000-06       Impact factor: 2.248

8.  Role of free oxygen radicals in noise-related hearing impairment.

Authors:  I Kaygusuz; A Oztürk; B Ustündağ; S Yalçin
Journal:  Hear Res       Date:  2001-12       Impact factor: 3.208

Review 9.  The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation.

Authors:  Khadija Alawi; Julie Keeble
Journal:  Pharmacol Ther       Date:  2009-11-05       Impact factor: 12.310

10.  Round window application of D-methionine provides complete cisplatin otoprotection.

Authors:  Kurtis D Korver; Leonard P Rybak; Craig Whitworth; Kathleen M Campbell
Journal:  Otolaryngol Head Neck Surg       Date:  2002-06       Impact factor: 3.497

View more
  40 in total

1.  The design and screening of drugs to prevent acquired sensorineural hearing loss.

Authors:  Debashree Mukherjea; Leonard P Rybak; Kelly E Sheehan; Tejbeer Kaur; Vickram Ramkumar; Sarvesh Jajoo; Sandeep Sheth
Journal:  Expert Opin Drug Discov       Date:  2011-03-15       Impact factor: 6.098

2.  Localized TRPA1 channel Ca2+ signals stimulated by reactive oxygen species promote cerebral artery dilation.

Authors:  Michelle N Sullivan; Albert L Gonzales; Paulo W Pires; Allison Bruhl; M Dennis Leo; Wencheng Li; Agathe Oulidi; Frederick A Boop; Yumei Feng; Jonathan H Jaggar; Donald G Welsh; Scott Earley
Journal:  Sci Signal       Date:  2015-01-06       Impact factor: 8.192

Review 3.  Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.

Authors:  Corné J Kros; Peter S Steyger
Journal:  Cold Spring Harb Perspect Med       Date:  2019-11-01       Impact factor: 6.915

Review 4.  An integrated view of cisplatin-induced nephrotoxicity and ototoxicity.

Authors:  Takatoshi Karasawa; Peter S Steyger
Journal:  Toxicol Lett       Date:  2015-06-20       Impact factor: 4.372

Review 5.  Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies.

Authors:  Mona Sedeek; Augusto C Montezano; Richard L Hebert; Stephen P Gray; Elyse Di Marco; Jay C Jha; Mark E Cooper; Karin Jandeleit-Dahm; Ernesto L Schiffrin; Jennifer L Wilkinson-Berka; Rhian M Touyz
Journal:  J Cardiovasc Transl Res       Date:  2012-06-19       Impact factor: 4.132

Review 6.  Early investigational drugs for hearing loss.

Authors:  Debashree Mukherjea; Sumana Ghosh; Puspanjali Bhatta; Sandeep Sheth; Srinivasan Tupal; Vikrant Borse; Thomas Brozoski; Kelly E Sheehan; Leonard P Rybak; Vickram Ramkumar
Journal:  Expert Opin Investig Drugs       Date:  2014-09-22       Impact factor: 6.206

7.  Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity.

Authors:  Kelly Sheehan; Sandeep Sheth; Debashree Mukherjea; Leonard P Rybak; Vickram Ramkumar
Journal:  J Vis Exp       Date:  2018-03-16       Impact factor: 1.355

Review 8.  siRNA-mediated knock-down of NOX3: therapy for hearing loss?

Authors:  Leonard P Rybak; Debashree Mukherjea; Sarvesh Jajoo; Tejbeer Kaur; Vickram Ramkumar
Journal:  Cell Mol Life Sci       Date:  2012-05-05       Impact factor: 9.261

9.  Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.

Authors:  Tejbeer Kaur; Vikrant Borse; Sandeep Sheth; Kelly Sheehan; Sumana Ghosh; Srinivasan Tupal; Sarvesh Jajoo; Debashree Mukherjea; Leonard P Rybak; Vickram Ramkumar
Journal:  J Neurosci       Date:  2016-04-06       Impact factor: 6.167

10.  Cannabinoid Signaling in Auditory Function and Development.

Authors:  Sumana Ghosh; Kendra Stansak; Bradley J Walters
Journal:  Front Mol Neurosci       Date:  2021-05-17       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.